You are here

Debiopharm

Merck KGaA pens $855M upfront, biobucks pact with Debiopharm for next-gen cancer asset

Fierce Biotech

Mon, 03/1/21 - 10:32 am

AI startup Nucleai has immuno-oncology treatment failures in its sights

Pharmaforum

Tue, 07/7/20 - 08:09 pm

artificial intelligence

immuno-oncology

Shasun Pharma in licensing pact with Debiopharm Group

MoneyControl, India

Sun, 04/14/13 - 12:23 pm

Curis lands $8M as cancer-drug trial advances

bizjournals.com

Sat, 02/13/10 - 10:48 am

Pfizer's Having a Garage Sale

Motley Fool

Fri, 01/8/10 - 03:18 pm

Medicines Company

Pfizer enters melanoma partnership with Debiopharm

Yahoo/AP

Thu, 01/7/10 - 10:01 am